Wilson Sonsini is pleased to support Westchester County Biosciences Accelerator (WCBA), Accelerator for Biosciences in CT (ABCT) and Biolabs@NYULangone as they present De-Risking Biotech: Leveraging Your Lawyers. For those that have started a business and likely have a lawyer, it is vital to engage the lawyer and the firm to provide significant tools and insights to help de-risk an enterprise, beyond just filing a patent and writing agreements. Panelists will discuss the legal landscape available to biotech startups and how to leverage lawyers to drive success and de-risk endeavors at various stages of a startup lifecycle.
Lori Doyle
ldoyle@wsgr.comDr. Craig Kenesky is an associate in the New York office of Wilson Sonsini Goodrich & Rosati. Craig applies his background in synthetic organic, medicinal, peptide, bioorganic, and computational chemistry to the prosecution of domestic and foreign patent applications, as well as due diligence, freedom to operate, portfolio development strategy, opinions, and IP counseling. Craig represents clients in numerous technology-focused industries, including the chemical, pharmaceutical, biotechnology, nanotechnology, diagnostic, neutriceutical, healthcare, process and manufacturing, energy, clean technology, biofuel, genomics, software, information technology, bioinformatics, scientific instrument, personalized medicine, and medical device sectors. He performs pre-transaction due diligence on behalf of both technology companies and venture capital groups, and he develops non-infringement and invalidity strategies for generic pharmaceutical companies.